Skip to main navigation
  • About
  • Pipeline
  • Patients
  • Investors
  • Contact Us

Investor Relations

  • Investors
  • Press Releases
  • Event Calendar
  • Stock Info
  • Governance
  • Financial Info
  • Shareholder Services
  • Presentations

Financial Information

  • SEC Filings

Shareholder Tools


  • Facebook
  • Google
  • LinkedIn
  • Twitter

SEC Filing Details

Document Details

Form
8-K/A
Filing Date
Jun 11, 2021
Document Date
May 26, 2021
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Bellerophon Therapeutics, Inc.
Issuer
BELLEROPHON THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT
© 2022 Bellerophon Therapeutics. All rights reserved.
  • Site Map
  • Terms of Use
  • Privacy Policy